CAPLIPOINT — Caplin Point Laboratories Cashflow Statement
0.000.00%
Last trade - 00:00
- IN₹96.35bn
- IN₹89.40bn
- IN₹14.67bn
- 96
- 13
- 95
- 82
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 2,269 | 2,695 | 3,136 | 3,858 | 4,514 |
Depreciation | |||||
Non-Cash Items | -43 | -245 | -139 | -165 | -332 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -1,626 | -2,319 | -709 | -795 | -1,918 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Net Change in Other Assets & Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 834 | 447 | 2,658 | 3,368 | 2,714 |
Capital Expenditures | -652 | -767 | -705 | -912 | -1,935 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -353 | 222 | 651 | -1,798 | -241 |
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -1,005 | -545 | -53.6 | -2,709 | -2,176 |
Financing Cash Flow Items | -0.6 | -4.95 | -15.4 | -14.6 | -7.8 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 898 | 798 | -240 | -407 | -282 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 735 | 701 | 2,362 | 250 | 268 |